Dr. Elizabeth Clayborne, Adjunct Assistant Professor of Emergency Medicine at the University of Maryland School of Medicine and Emergency Physician at UM Capital Region Medical Center, joins Yahoo Finance to discuss the latest in the coronavirus pandemic.
Shares of vaccine maker Moderna hit highs of nearly $500 earlier this year. No doubt, Moderna has been an exceptional investment over the past year, soaring 350% while the S&P 500 has risen by just 29%. Two stocks I'd buy instead of Moderna are AstraZeneca (NASDAQ: AZN) and Merck (NYSE: MRK).
The Zacks Analyst Blog Highlights: Microsoft, Mastercard, Pfizer, PepsiCo and Merck